Evidence map›Paper›PMID 38222193›Full record

ArticleCureus2023

A High Preoperative Blood Urea Nitrogen to Serum Albumin Ratio Does Not Predict Worse Outcomes Following the Robotic-Assisted Pulmonary Lobectomy for Lung Cancer.

Allison O Dumitriu Carcoana, Kristie M Labib, Cole R Fiedler, Jenna C Marek, Lauren C Ladehoff, William J West, Jose A Malavet, William N Doyle, Carla C Moodie, Joseph R Garrett and 4 more

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cureus, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.5field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 1 institution in 1 country.

Allison O Dumitriu CarcoanaMedical Education, University of South Florida Health Morsani College of Medicine, Tampa, USA.
Kristie M LabibMedical Education, University of South Florida Health Morsani College of Medicine, Tampa, USA.
Cole R FiedlerMedical Education, University of South Florida Health Morsani College of Medicine, Tampa, USA.
Jenna C MarekMedical Education, University of South Florida Health Morsani College of Medicine, Tampa, USA.
Lauren C LadehoffMedical Education, University of South Florida Health Morsani College of Medicine, Tampa, USA.
William J WestMedical Education, University of South Florida Health Morsani College of Medicine, Tampa, USA.
Jose A MalavetMedical Education, University of South Florida Health Morsani College of Medicine, Tampa, USA.
William N DoyleMedical Education, University of South Florida Health Morsani College of Medicine, Tampa, USA.
Carla C MoodieThoracic Oncology, Moffitt Cancer Center, Tampa, USA.
Joseph R GarrettThoracic Oncology, Moffitt Cancer Center, Tampa, USA.
Jenna R TewThoracic Oncology, Moffitt Cancer Center, Tampa, USA.
Jobelle Joyce Anne R BaldonadoThoracic Oncology, Moffitt Cancer Center, Tampa, USA.
Jacques P FontaineThoracic Oncology, Moffitt Cancer Center, Tampa, USA.
Eric TolozaThoracic Oncology, Moffitt Cancer Center, Tampa, USA.
University of South Florida · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe blood urea nitrogen to serum albumin ratio (BAR) is an emerging prognostic parameter of interest. The utility of BAR as a prognostic factor has not been analyzed in lung cancer patients undergoing pulmonary lobectomy. We evaluated the ability of High BAR to predict worse outcomes after robotic-assisted pulmonary lobectomy (RAPL) for lung cancer.

methodsWe retrospectively analyzed 400 patients who underwent RAPL from September 2010 to March 2022 by one surgeon. Patients were stratified by Low BAR (<6.25 mg/g) and High BAR (≥6.25 mg/g). Patients' demographics, tumor characteristics, comorbidities, surgical complications, outcomes, and survival were collected and compared by High and Low BAR groups. The primary outcome of interest was 30-day mortality.

resultsReceiver operator curves (ROC) confirmed that 6.25 was an optimal threshold for estimating mortality based on Low and High BAR. There were no differences in surgical complications or outcomes between the Low and High BAR groups. The ability of BAR to predict 30-day mortality was evaluated with the area under the curve (AUC) analysis, which showed that higher BAR could not predict mortality (AUC=0.655; 95% CI, 0.435-0.875;

conclusionHigh BAR did not predict worse outcomes after RAPL for lung cancer in our study. Further studies are needed to better determine the prognostic ability of BAR in lower-risk populations.

Indexed as

blood urea nitrogenlung canceroutcomespulmonary lobectomyrobotic surgeryserum albumin

Identifiers

PMID38222193
PMCPMC10786433
OpenAlexW4389669118

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.